77829889 - ZEALAND PHARMA A/S

Information

  • Trademark
  • 77829889
  • Serial Number
    77829889
  • Filing Date
    September 18, 2009
    14 years ago
  • Transaction Date
    October 31, 2011
    12 years ago
  • Status Date
    October 31, 2011
    12 years ago
  • Location Date
    October 31, 2011
    12 years ago
  • Status Code
    602
  • Current Location
    TMEG LAW OFFICE 109 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    CROSS, TRACY L
  • Attorney Docket Number
    66886/85424
    Attorney Name
    Thomas A. Polcyn
    Law Office Assigned Location Code
    L90
  • Owners
Mark Drawing Code
4000
Mark Identification
ZEALAND PHARMA A/S
Case File Statements
  • D10000: "PHARMA A/S"
  • GS0011: Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; peptide substrates used in analyzing and detecting certain toxins for laboratory or research use
  • GS0051: Pharmaceutical preparations for the treatment of diseases, illnesses and ailments in humans and animals, namely, infectious and parasitic diseases, neoplasms, endocrine disorders, nutritional and metabolic diseases, immunity disorders, blood disorders, mental disorders, disorders of the nervous system and sensory organs, musculoskeletal system disorders, connective tissue disorders, circulatory system disorders, respiratory system disorders, digestive system and genitourinary system disorders, skin disorders, pregnancy and childbirth disorders, congenital anomalies, poisoning, communicable diseases, neurological diseases, psychological conditions, inflammatory diseases, reproductive diseases and sexual dysfunction; chemical preparations for medical and pharmaceutical purposes, namely, for the treatment of diseases, illnesses and ailments in humans and animals, namely, infectious and parasitic diseases, neoplasms, endocrine disorders, nutritional and metabolic diseases, immunity disorders, blood disorders, mental disorders, disorders of the nervous system and sensory organs, musculoskeletal system disorders, connective tissue disorders, circulatory system disorders, respiratory system disorders, digestive system and genitourinary system disorders, skin disorders, pregnancy and childbirth disorders, congenital anomalies, poisoning, communicable diseases, neurological diseases, psychological conditions, inflammatory diseases, reproductive diseases and sexual dysfunction; first aid kits; diagnostic kits comprised of pharmaceutical and chemical preparations for the treatment of diseases, illnesses, and ailments in humans and animals, namely, infectious and parasitic diseases, neoplasms, endocrine disorders, nutritional and metabolic diseases, immunity disorders, blood disorders, mental disorders, disorders of the nervous system and sensory organs, musculoskeletal system disorders, connective tissue disorders, circulatory system disorders, respiratory system disorders, digestive system and genitourinary system disorders, skin disorders, pregnancy and childbirth disorders, congenital anomalies, poisoning, communicable diseases, neurological diseases, psychological conditions, inflammatory diseases, reproductive diseases and sexual dysfunction; synthetic peptides for pharmaceutical purposes
  • GS0351: Exploitation of scientific research and technology, namely, promoting collaboration and the exchange of information and resources within the scientific, research and medical communities to achieve advances in the field of health care
  • GS0421: Scientific and technological services and research and design relating thereto in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; industrial analysis and research services in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; design and development of computer hardware and software; medical, biological, biotechnological, genetic, laboratory and pharmaceutical research, design and development services; design and development of computer hardware and software; medical, biological, biotechnological, genetic and pharmaceutical research, design and development services; laboratory research in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; information and consultancy services relating to all the aforesaid
  • GS0441: Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services; dentistry services; medical analysis for the diagnosis and treatment of persons; pharmaceutical advice
Case File Event Statements
  • 10/31/2011 - 12 years ago
    25 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2
  • 10/31/2011 - 12 years ago
    24 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2
  • 3/21/2011 - 13 years ago
    23 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 3/21/2011 - 13 years ago
    22 - FINAL REFUSAL E-MAILED Type: GNFR
  • 3/21/2011 - 13 years ago
    21 - FINAL REFUSAL WRITTEN Type: CNFR
  • 2/18/2011 - 13 years ago
    20 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/18/2011 - 13 years ago
    19 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/18/2011 - 13 years ago
    18 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 8/19/2010 - 13 years ago
    17 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 8/19/2010 - 13 years ago
    16 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 8/19/2010 - 13 years ago
    15 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 8/12/2010 - 13 years ago
    14 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX
  • 7/16/2010 - 13 years ago
    13 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR
  • 7/7/2010 - 13 years ago
    12 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 7/6/2010 - 13 years ago
    11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 6/2/2010 - 13 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 6/2/2010 - 13 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/2/2010 - 13 years ago
    8 - ASSIGNED TO LIE Type: ALIE
  • 5/18/2010 - 13 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 12/26/2009 - 14 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 12/26/2009 - 14 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 12/26/2009 - 14 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 12/16/2009 - 14 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/22/2009 - 14 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 9/22/2009 - 14 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP